The newly expanded RSV vaccination programme should reduce hospital admissions and better protect vulnerable patients ...
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...
Results of a phase 2 study demonstrate that vixarelimab may be a promising therapy option for adults with moderate to severe prurigo nodularis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results